Aurisco Pharmaceutical Co.,Ltd. (605116.SS)
Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
At close: 03:00PM CST
| Previous close | 22.16 |
| Open | 22.24 |
| Bid | 24.14 x N/A |
| Ask | 24.15 x N/A |
| Day's range | 22.24 - 24.38 |
| 52-week range | 17.33 - 26.63 |
| Volume | |
| Avg. volume | 1,652,100 |
| Market cap | 9.81B |
| Beta (5Y monthly) | -0.28 |
| PE ratio (TTM) | 30.19 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 0.22 (0.99%) |
| Ex-dividend date | 06 June 2024 |
| 1y target est | N/A |
- PR Newswire
Aurisco gets Auxiton® (Dydrogesterone) as first generic approval in China
Aurisco Pharmaceutical has good reasons to celebrate. On its 25th anniversary, the high-tech pharmaceutical company dedicated to innovation has received its first Marketing Authorization Approval in China for AUXITON®, the oral finished dosage form of Dydrogesterone, from China's Health Authority, the NMPA. Aurisco is the only company holding both an active USDMF and a valid CEP – the Certificate of compliance with the European Pharmacopoeia, issued by the EDQM for the drug substance.
© 2024 Yahoo. All rights reserved.